Literature DB >> 11200685

Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases.

B Celet1, G Akman-Demir, P Serdaroğlu, S P Yentür, B Taşci, J M van Noort, M Eraksoy, G Saruhan-Direskeneli.   

Abstract

alpha B-Crystallin, a small heat shock protein, is an immunodominant antigen with increased tissue expression in demyelination. To investigate the humoral response against alpha B-crystallin, the sera and CSF samples of patients with multiple sclerosis (MS), Guillain-Barré syndrome (GBS), neuro-Behçet's disease (NBD) and other non-inflammatory neurological diseases (NIND) were screened by enzyme-linked immunosorbent assay for anti-alpha B-crystallin IgG and IgM antibodies. Serum and CSF IgG antibody responses to alpha B-crystallin were significantly elevated only in NBD patients (serum IgG, NBD 1.29 +/- 0.49 vs. NIND 0.95 +/- 0.39, P = 0.01; CSF IgG, NBD 1.22 +/- 0.64 vs. NIND 0.81 +/- 0.35, P = 0.01). Similarly, high serum IgM antibody titres were also detected in NBD (1.83 +/- 0.72 vs. 1.16 +/- 0.49, P = 0.0005) and in MS (1.57 +/- 1.07, P = 0.046), whereas elevated CSF IgM responses were observed only in GBS (2.09 +/- 1.09 vs. 1.41 +/- 0.7, P = 0.007). Humoral responses against alpha B-crystallin are increased in NBD and GBS, which may implicate this central nervous system antigen in the causation and pathogenesis of these inflammatory nervous system disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11200685     DOI: 10.1007/s004150070049

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

Review 1.  Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors:  H Direskeneli
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 2.  Extracellular small heat shock proteins: exosomal biogenesis and function.

Authors:  V Sudhakar Reddy; Satish K Madala; Jamma Trinath; G Bhanuprakash Reddy
Journal:  Cell Stress Chaperones       Date:  2017-10-30       Impact factor: 3.667

3.  Chaperone activity of α B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis.

Authors:  Jonathan B Rothbard; Xiaoyan Zhao; Orr Sharpe; Michael J Strohman; Michael Kurnellas; Elizabeth D Mellins; William H Robinson; Lawrence Steinman
Journal:  J Immunol       Date:  2011-02-25       Impact factor: 5.422

Review 4.  Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells.

Authors:  Salih Pay; Ismail Simşek; Hakan Erdem; Ayhan Dinç
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

Review 5.  Can innate and autoimmune reactivity forecast early and advance stages of age-related macular degeneration?

Authors:  Grazyna Adamus
Journal:  Autoimmun Rev       Date:  2017-01-28       Impact factor: 9.754

6.  The Presence of Autoantibodies Against Vascular and Nervous Tissue in Sera From Patients with Neuro-Behçet's Disease.

Authors:  Ayşe İlksen Colpak; Umut Kalyoncu; Yasemin Gürsoy Özdemir
Journal:  Noro Psikiyatr Ars       Date:  2014-06-01       Impact factor: 1.339

7.  Cross-reactivity of antibodies against leptospiral recurrent uveitis-associated proteins A and B (LruA and LruB) with eye proteins.

Authors:  Ashutosh Verma; Pawan Kumar; Kelly Babb; John F Timoney; Brian Stevenson
Journal:  PLoS Negl Trop Dis       Date:  2010-08-03

Review 8.  Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making.

Authors:  Violaine K Harris; Saud A Sadiq
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

9.  Associations of seroreactivity against crystallin proteins with disease activity and cataract in patients with uveitis.

Authors:  Ling Chen; Gary N Holland; Fei Yu; Ralph D Levinson; Kirsten J Lampi; Joseph Horwitz; Lynn K Gordon
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-06       Impact factor: 4.799

Review 10.  B cells in multiple sclerosis.

Authors:  Mark P Burgoon; Donald H Gilden; Gregory P Owens
Journal:  Front Biosci       Date:  2004-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.